Table 1.
Sample characteristics.
| Subjects who completed translated version (n = 53) |
Subjects tested and retested (n = 25) |
All subjects (n = 321) |
Subsample with information on items (n = 82/321) |
P value for difference |
|
|---|---|---|---|---|---|
| Age (years), mean (SD); range | 46.56 (11.61); range: 18–67 | 50 (11); range 35–76 | 47.55 (11.9); range: 18–76 | 44.55 (10.2); range: 21–76 | 0.008 |
| Gender: female/male | 32 (60.37%)/21 (39.63%) | 14 (56%)/11 (44%) | 163 (50.8%)/158 (49.2%) | 49 (59.8%)/33 (40.2%) | 0.079 |
| Disease duration (Years), mean (SD); range | 14.9 (9.1); range: 1–42 | 12 (5.5); range 2–24 | 13.8 (8.3); range: 1–42 | 13.4 (6.4); range: 2–34 | 0.57 |
| EDSS score, mean (range) | 5.2; range: 1.5–6.5 | 5.5; range: 3–7 | 4.46; range: 0–6.5 | 4.46; range: 1–7 | 0.74 |
| Relapsing-remitting course (RR), n (%) | 26 (49.1%) | 9 (36%) | 185 (57.6%) | 39 (47.6%) | 0.046 |
| Secondary progressive course (SP), n (%) | 15 (28.3%) | 11 (44%) | 92 (28.7%) | 32 (39.1%) | |
| Primary progressive course (PP), n (%) | 12 (22.6%) | 5 (20%) | 43 (13.4%) | 11 (13.4%) | |
| Clinically isolated syndrome (CIS), n (%) | 0 (0%) | 0 (0%) | 1 (0.3%) | 0 (0%) |